Worldwide over 25 million people have cancer and more than 10 million die from it each year. There is a growing focus on cancer diagnosis because accurate and timely detection of the disease means a better chance for patient survival and lower treatment costs. Today's diagnostic screening methods are often inadequate due to their low accuracy. So far, the high complexity of blood prohibited the sensitive and high throughput profiling of patient sample sets large enough to reliably detect cancer-indicating differences. Yet despite intensive interest and investment, only a few cancer biomarkers are used in clinical practice. This book will give you an overview of the establishment of a new strategy for the discovery, verification and validation of cancer protein biomarkers. Thereby different technological and biological aspects are discussed. Finally, the preliminary results of a prostate cancer study, which resulted in the identification of a panel of new protein biomarker superior to the current standard PSA (prostate specific antigen), are shown.
Le informazioni nella sezione "Riassunto" possono far riferimento a edizioni diverse di questo titolo.
Ralph Schiess, Dr. sc. ETH: Studies in biochemistry at theInstitute of Molecular Systems Biology, ETH Zurich with a focus on mass spectrometrybased proteomics and protein biomarker research, Ph.D. received 2008.
Le informazioni nella sezione "Su questo libro" possono far riferimento a edizioni diverse di questo titolo.
EUR 28,80 per la spedizione da Regno Unito a Italia
Destinazione, tempi e costiEUR 13,29 per la spedizione da Germania a Italia
Destinazione, tempi e costiDa: Versandbuchhandlung Kisch & Co., Fürstenberg OT Blumenow, Germania
Taschenbuch. Condizione: Neu. Neu Neuware; original eingeschweisst; Rechnung mit MwSt.; new item, still sealed; -Worldwide over 25 million people have cancer and more than 10 million die from it each year. There is a growing focus on cancer diagnosis because accurate and timely detection of the disease means a better chance for patient survival and lower treatment costs. Today's diagnostic screening methods are often inadequate due to their low accuracy. So far, the high complexity of blood prohibited the sensitive and high throughput profiling of patient sample sets large enough to reliably detect cancer-indicating differences. Yet despite intensive interest and investment, only a few cancer biomarkers are used in clinical practice. This book will give you an overview of the establishment of a new strategy for the discovery, verification and validation of cancer protein biomarkers. Thereby different technological and biological aspects are discussed. Finally, the preliminary results of a prostate cancer study, which resulted in the identification of a panel of new protein biomarker superior to the current standard PSA (prostate specific antigen), are shown. 164 pp. Deutsch. Codice articolo INF1100262105
Quantità: 2 disponibili
Da: moluna, Greven, Germania
Condizione: New. Dieser Artikel ist ein Print on Demand Artikel und wird nach Ihrer Bestellung fuer Sie gedruckt. Worldwide over 25 million people have cancer and more than 10 million die from it each year. There is a growing focus on cancer diagnosis because accurate and timely detection of the disease means a better chance for patient survival and lower treatment cos. Codice articolo 5405026
Quantità: Più di 20 disponibili
Da: BuchWeltWeit Ludwig Meier e.K., Bergisch Gladbach, Germania
Taschenbuch. Condizione: Neu. This item is printed on demand - it takes 3-4 days longer - Neuware -Worldwide over 25 million people have cancer and more than 10 million die from it each year. There is a growing focus on cancer diagnosis because accurate and timely detection of the disease means a better chance for patient survival and lower treatment costs. Today's diagnostic screening methods are often inadequate due to their low accuracy. So far, the high complexity of blood prohibited the sensitive and high throughput profiling of patient sample sets large enough to reliably detect cancer-indicating differences. Yet despite intensive interest and investment, only a few cancer biomarkers are used in clinical practice. This book will give you an overview of the establishment of a new strategy for the discovery, verification and validation of cancer protein biomarkers. Thereby different technological and biological aspects are discussed. Finally, the preliminary results of a prostate cancer study, which resulted in the identification of a panel of new protein biomarker superior to the current standard PSA (prostate specific antigen), are shown. 164 pp. Deutsch. Codice articolo 9783838106397
Quantità: 2 disponibili
Da: AHA-BUCH GmbH, Einbeck, Germania
Taschenbuch. Condizione: Neu. nach der Bestellung gedruckt Neuware - Printed after ordering - Worldwide over 25 million people have cancer and more than 10 million die from it each year. There is a growing focus on cancer diagnosis because accurate and timely detection of the disease means a better chance for patient survival and lower treatment costs. Today's diagnostic screening methods are often inadequate due to their low accuracy. So far, the high complexity of blood prohibited the sensitive and high throughput profiling of patient sample sets large enough to reliably detect cancer-indicating differences. Yet despite intensive interest and investment, only a few cancer biomarkers are used in clinical practice. This book will give you an overview of the establishment of a new strategy for the discovery, verification and validation of cancer protein biomarkers. Thereby different technological and biological aspects are discussed. Finally, the preliminary results of a prostate cancer study, which resulted in the identification of a panel of new protein biomarker superior to the current standard PSA (prostate specific antigen), are shown. Codice articolo 9783838106397
Quantità: 1 disponibili
Da: buchversandmimpf2000, Emtmannsberg, BAYE, Germania
Taschenbuch. Condizione: Neu. Neuware -Worldwide over 25 million people have cancer and more than 10 million die from it each year. There is a growing focus on cancer diagnosis because accurate and timely detection of the disease means a better chance for patient survival and lower treatment costs. Today¿s diagnostic screening methods are often inadequate due to their low accuracy. So far, the high complexity of blood prohibited the sensitive and high throughput profiling of patient sample sets large enough to reliably detect cancer-indicating differences. Yet despite intensive interest and investment, only a few cancer biomarkers are used in clinical practice. This book will give you an overview of the establishment of a new strategy for the discovery, verification and validation of cancer protein biomarkers. Thereby different technological and biological aspects are discussed. Finally, the preliminary results of a prostate cancer study, which resulted in the identification of a panel of new protein biomarker superior to the current standard PSA (prostate specific antigen), are shown.Books on Demand GmbH, Überseering 33, 22297 Hamburg 164 pp. Deutsch. Codice articolo 9783838106397
Quantità: 2 disponibili
Da: preigu, Osnabrück, Germania
Taschenbuch. Condizione: Neu. Proteomic Strategy for Cancer Biomarker Discovery | Focus on Cancer Specific Proteins for Diagnostic Purposes | Ralph Schiess | Taschenbuch | 164 S. | Deutsch | 2015 | Südwestdeutscher Verlag für Hochschulschriften AG Co. KG | EAN 9783838106397 | Verantwortliche Person für die EU: Südwestdt. Verl. f. Hochschulschrift., Brivibas Gatve 197, 1039 RIGA, LETTLAND, customerservice[at]vdm-vsg[dot]de | Anbieter: preigu. Codice articolo 101562589
Quantità: 5 disponibili
Da: Mispah books, Redhill, SURRE, Regno Unito
paperback. Condizione: Like New. Like New. book. Codice articolo ERICA82938381063935
Quantità: 1 disponibili